Drug Search Results
More Filters [+]

Emerald

Alternative Names: Emerald, mc-10, mc10, mc 10
Latest Update: 2024-07-12
Latest Update Note: News Article

Product Description

Utilizing wireless wearable sensors, MC10 BiostampRC, to capture quantitative biometric and movement-based data. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT04219670)

Mechanisms of Action: Device

Novel Mechanism: No

Modality: Device

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Canada | Chile | Colombia | Dominican Republic | India | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Emyria
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Emerald

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Emerald-NRAD

N/A

Not yet recruiting

Alzheimer Disease|Cognitive Dysfunction

2025-04-30

OPAL

N/A

Completed

Parkinson's Disease

2024-05-07

EMERALD

N/A

Completed

Adenocarcinoma|Esophageal Cancer|Gastroesophageal Reflux|Barrett Esophagus|Gastrointestinal Cancer|Esophagitis

2024-04-24

SENS-101-RSRT

N/A

Completed

Rett Syndrome

2023-03-01

Recent News Events